Childhood Uveitis Initial Management and One-year Outcomes
Childhood Uveitis Not Associated With Juvenile Idiopathic Arthritis: Incidence, Initial Management and One-year Outcomes
1 other identifier
observational
500
1 country
1
Brief Summary
The investigators wish to establish a robust estimate of the incidence of inflammation inside the eye (uveitis) in children age 0-16 years in the UK, which hospitals children present to, where they are referred to, which treatment they receive during the first year after diagnosis, and how well they can see at the end of the first year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 25, 2015
CompletedFirst Posted
Study publicly available on registry
July 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedApril 12, 2022
April 1, 2022
2.3 years
June 25, 2015
April 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The primary outcome measure will be the total number of reported cases of uveitis.
A clinical proforma will be sent to the investigators collect clinical details about the case. At 12 months, a followup questionnaire will be sent.
1 year
Study Arms (1)
1
Any child (aged 0-16 years) with a new diagnosis of uni or bilateral uveitis.
Interventions
Eligibility Criteria
Any child (aged 0-16 years) with a new diagnosis of uni or bilateral uveitis.
You may qualify if:
- Any child (aged 0-16 years) with a new diagnosis of uni or bilateral uveitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moorfields Eye Hospital NHS Foundation Trust
London, EC1V 2PD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annegret Dahlmann-Noor, Dr Med PhD
Moorfields Eye Hospital NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2015
First Posted
July 3, 2015
Study Start
November 1, 2014
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
April 12, 2022
Record last verified: 2022-04